Saturday 4th June 2016

Childhood Scleroderma: Staying One Step Ahead of a Rare Disease

Clare Pain, MD, consultant pediatric rheumatologist in the Department of Rheumatology at Alder Hey Children's NHS Foundation Trust in Liverpool, England, further explained the disease.

Read Article

Thursday 26th May 2016

Cytori Fully Enrols Pivotal US Phase III Scleroderma Trial

Cytori Therapeutics Inc. announces that its US FDA-approved phase III STAR trial has enrolled its 80th patient (100% of target enrolment). All 80 patients enrolled thus far in both trial arms have been successfully treated without complications. Full trial data are expected to be available in mid-2017.

Read Article

Wednesday 25th May 2016

Everyone has a story, here's mine...

Read Article

Monday 23rd May 2016

Report: British Society for Rheumatology (BSR) Conference 2016

On Tuesday 26th through to the 28th of April, The British Society for Rheumatology held their annual conference, with this year’s venue being in Glasgow.

Read Article

Saturday 21st May 2016

Chemotherapy Isn't Only for Cancer

When you hear the word chemotherapy what immediately comes to mind? Cancer. Bald. Nausea. Vomiting. Infusions. Sterility. Bone Pain?

Read Article

Thursday 19th May 2016

My Experiences of Living with Raynaud`s

I have had primary Raynaud`s since I was small and that was before my teenage years began. The symptoms I have always had are cold hands and feet. Being so young I never understood why I was so often cold.

Read Article

Tuesday 17th May 2016

National Event in London

EULAR’s 2016 annual congress is at the Excel Centre in London, commencing 8th June, Wednesday afternoon and closing on Saturday 11th June.

Read Article

Friday 13th May 2016

Phase 2 Trial Suggests Tocilizumab May Be of Benefit to Systemic Sclerosis Patients

Read Article

Wednesday 11th May 2016

Protein, Netrin-1, Seen to Promote Lung Fibrosis in Early Scleroderma Study

Read Article

Friday 6th May 2016

Cumberland Readying a Phase 2 Trial of Oral Drug, Ifetroban, to Treat Scleroderma

Cumberland Pharmaceuticals, Inc., recently announced the addition to its drug pipeline of Vasculan (ifetroban), an oral capsule that soon will enter clinical testing as a treatment of systemic sclerosis (SSc), or scleroderma.

Read Article